Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Equillium, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Equillium, Inc. secured $2.19 million in funding through a private placement with RA Capital Healthcare Fund, issuing 1,179,508 shares at $1.854 per share, with closing expected March 13, 2026. This capital infusion supports the company's autoimmune disease therapy development and strengthens its financial position.
Key Takeaways
Equillium raised approximately $2.19 million through private placement of common stock at $1.854 per share
RA Capital Healthcare Fund, L.P. is the sole investor in this Securities Purchase Agreement
2 more takeaways